Zeo ScientifiX, Inc.

ZEOX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Apr 2026 Jan 2026 Oct 2025 Jul 2025 Apr 2025 Jan 2025 Oct 2024 Jul 2024
Revenue $2.6M $1.4M $1.7M $1.3M $1.1M $1.1M $1.2M $1.1M
Cost of Revenue $526.0K $281.0K $256.0K $228.0K $256.0K $191.0K $225.0K $176.0K
Gross Profit $2.1M $1.2M $1.4M $1.1M $893.0K $899.0K $1.0M $915.0K
Gross Margin 79.6% 80.6% 84.5% 82.5% 77.7% 82.5% 81.9% 83.9%
Operating Expenses
Research & Development $31.0K $19.0K $42.0K $6.0K $57.0K $75.0K
SG&A Expense $2.6M $2.0M $2.1M $3.1M $2.3M $2.2M $2.4M $2.1M
Operating Income $-512.0K $-878.0K $-668.0K $-2.1M $-1.4M $-1.3M $-1.4M $-1.2M
Operating Margin -19.8% -60.7% -40.4% -158.6% -121.3% -115.0% -114.5% -107.1%
Interest Expense $11.0K $10.0K $32.0K $23.0K $21.0K $22.0K $22.0K $23.0K
Pretax Income
Income Tax Expense
Net Income $-145.0K $-852.0K $-815.0K $-2.1M $-1.4M $-1.2M $-1.3M $-1.0M
Net Margin -5.6% -58.9% -49.3% -158.7% -121.1% -114.0% -100.8% -92.8%
EPS (Basic) $-0.02 $-0.12 $-0.12 $-0.32 $-0.22 $-0.20 $-0.18 $-0.16
EPS (Diluted) $-0.02 $-0.12 $-0.12 $-0.32 $-0.22 $-0.20 $-0.18 $-0.16
Shares Outstanding (Basic) 7.8M 7.0M 6.4M 6.4M 6.3M 6.3M 6.3M 6.3M
Shares Outstanding (Diluted) 7.8M 7.0M 6.4M 6.4M 6.3M 6.3M 6.3M 6.3M
Dividends Per Share
← Newer Page 1 of 8 Older →